http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Labcorp Acquires Clinical Outreach Laboratory Services From RWJBarnabas Health
-
BD, Labcorp Collaborate to Develop Flow Cytometry-Based Companion Diagnostics for Matching Patients with Treatments
-
Labcorp Announces 2022 Second Quarter Results
-
Labcorp (LH) to Spin Off Clinical Development Business
-
Labcorp to Spin Off Clinical Development Business
-
Labcorp Earns Top Score on 2022 Disability Equality Index
-
New Labcorp Test Report Helps Identify Insect Stings and Improve Therapy Decisions to Combat Allergic Reactions
-
Labcorp Expands Automated Clinical Trial Kit Production Line at European Operations Center
-
Labcorp to Announce Second Quarter Financial Results on July 28, 2022
-
Labcorp Declares Quarterly Dividend
-
Labcorp (LH) Launches New Test to Identify and Confirm Neurodegenerative Disease
-
Labcorp Launches New Test to Identify and Confirm Neurodegenerative Disease
-
Labcorp (LH) Forms Strategic Partnership With MD Anderson Cancer Center Foundation Spain to Increase Access to Early Phase Oncology Clinical Trials
-
Labcorp Forms Strategic Partnership With MD Anderson Cancer Center Foundation Spain to Increase Access to Early Phase Oncology Clinical Trials
-
Labcorp (LH) First National Laboratory to Offer Monkeypox Test
-
Labcorp First National Laboratory to Offer Monkeypox Test
-
Labcorp (LH) Announces Laboratory Expansion in Japan Through BML Collaboration
-
Labcorp Plans Laboratory Expansion in Japan Through BML Collaboration
-
Tigerlily Foundation and Labcorp Collaborate to Increase Clinical Trial Diversity for Women of Color
-
Labcorp (LH) Announces Data Collaboration With HealthVerity
-
Labcorp Enhances Clinical Trial and Drug Development Capabilities Through Real World Data Collaboration With HealthVerity
-
Labcorp Expands Access to Comprehensive Genomic Testing Through New Lung Cancer Program
-
Labcorp Launches New Test for People With Skin Cancer
-
Labcorp (LH) Granted Emergency Use Authorization for Non-Prescription At-Home Collection Kit for Combined COVID-19, Flu and RSV Detection
-
Labcorp Receives Emergency Use Authorization for First Non-Prescription At-Home Collection Kit for Combined COVID-19, Flu and RSV Detection
-
Labcorp to Speak at the UBS 2022 Global Healthcare Conference
-
Labcorp Launches First-of-its-kind At-home Collection Device for Diabetes Risk Testing
-
Labcorp (LH) Acquires Diagnostic Clinical Laboratory Services From AtlantiCare
-
Labcorp Acquires Diagnostic Clinical Laboratory Services From AtlantiCare
-
Labcorp to Webcast Its Annual Meeting of Shareholders
-
Labcorp Announces 2022 First Quarter Results
-
Labcorp Launches Convenient Home Diagnostic Test Collection Service in Collaboration With Getlabs
-
Labcorp Enhances Cell and Gene Therapy Development Support Through Collaboration With Xcell Biosciences
-
Labcorp Initiates Quarterly Dividend
-
Ventus Therapeutics Appoints Victor Lobanov, PhD, as Head of Computational Sciences
-
Labcorp to Announce First Quarter Financial Results on April 28, 2022
-
New Labcorp Offering Makes Detecting, Measuring Unintentional Gluten Consumption Simple and Effective
-
Labcorp (LH) Enters Strategic Relationship With Prisma Health
-
Labcorp Enters Into Strategic Relationship With Prisma Health
-
Walgreens (WBA) and Labcorp (LH) Offer At-Home COVID-19 PCR Test Collection Kits At No Cost Nationwide
-
Walgreens and Labcorp Offer At-Home COVID-19 PCR Test Collection Kits At No Cost Nationwide
-
Labcorp Completes Acquisition of Personal Genome Diagnostics
-
Labcorp Announces 2021 Fourth Quarter and Full-Year Results
-
Labcorp (LH) Enters Comprehensive, Long-Term Laboratory Relationship With Ascension
-
Labcorp Enters Comprehensive, Long-Term Laboratory Relationship With Ascension
-
Labcorp Opens New Laboratory in South Bend, Expanding Services and Access in the Midwest
-
Labcorp Launches Labcorp OnDemand Digital Health Platform
-
Gabriela Perez Joins Big Health as Chief Commercial Officer
-
Labcorp Named to Fortune® Magazine’s 2022 ‘World’s Most Admired Companies’ List for the Fourth Time
-
Labcorp Earns 100% on Human Rights Campaign Foundation’s Annual Scorecard on LGBTQ+ Workplace Equality

